Besides, dual GLP-1/GIP receptor agonists (DA-JC4, DA5-CH, DA-JC1 and DA-CH3) reduced inflammation response, amyloid plaques and tau phosphorylation in brain, reversed memory loss, and enhanced synaptic plasticity in hippocampus of APP/PS1 mice (186, 234, 236, 238)
[18] Vichaya EG, et al
"Effects of tesamorelin (TH9507), a growth hormone-releasing factor analog, in HIV-infected patients with excess abdominal fat: a pooled analysis of two multicenter, double-blind placebo-controlled phase 3 trials with safety extension data." Journal of Acquired Immune Deficiency Syndromes, 2010
Cold and flu medicines, sleep aids, and prescription drugs may all include hidden doses
View Product Article A1 Previously in this cluster Glutathione The Tripeptide at the Centre of Cellular Redox Biology Codeage The Longevity Code Pillar 03 the cellular dimension of the longevity code
Only 13 state Medicaid programs nationwide cover GLP-1s for obesity as of January 2026, down from 16 in October 2025